Company news

CTT Pharmaceutical Holdings, Inc. news in 2025

CTT Pharmaceutical Holdings, Inc.'s news releases, calls and decks from 2025, newest first.

View company

CTT Pharmaceutical Holdings, Inc. Files Form S-1 Registration Statement and Advances Equity Line of Credit and Scientific Development Milestones

December 30, 2025

CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics

December 16, 2025

CTT Pharma CEO Issues Letter to Shareholders

December 2, 2025

CTT Pharma's CEO Will Issue a Letter to Shareholders

November 20, 2025

CTT Pharma's CEO will issue a Letter to Shareholders

November 20, 2025

CTT Pharma Signs Contract for $3 Million Equity Line of Credit

September 10, 2025

CTT Pharma Grant Updates

June 10, 2025

OTC Markets Group Welcomes New OTCQB Companies – March 17

March 17, 2025

CTT Pharma's CEO Issues Letter to Shareholders

March 11, 2025

CTT Pharma Uplists to the OTCQB Today

March 9, 2025

CTT Pharmaceuticals Holdings, Inc. Announces Uplisting to OTCQB Market Trading

March 4, 2025

CTT Pharma Gives Uplisting Update

March 2, 2025

CTT Pharma Gives Update On U.S. and European Patents

February 24, 2025

CTT Pharma Gives Update On NSF Grant

February 11, 2025

CTT Pharma Adds Independent Director With NIH/NSF Experience

February 4, 2025

CTT Pharma Reduces Authorized Share Count

February 2, 2025

CTT Pharma Submits Proposal for NIH Grant

January 29, 2025

Retransmission: CTT Pharma and Johns Hopkins University Submits Proposal for $15 Million NIH Grant for Smoking Cessation

January 27, 2025

CTT Pharma has engaged The OTC Markets to Uplist to The OTCQB

January 21, 2025

CTT Pharma will issue a news release January 22, 2025

January 20, 2025

CTT Pharma and Johns Hopkins University Submit Proposal for $15 Million NIH Grant For Smoking Cessation

January 6, 2025

CTT Pharma Update

January 5, 2025